A critical discovery in cancer investigation is emerging with the use of nanobodies to reactivate damaged p53. This essential cancer protector protein is frequently disabled in several types of malignancies, leading https://bookmark-vip.com/story22060361/mini-antibodies-revive-the-p53-protein-a-new-approach-for-cancer-management